Elite Pharmaceuticals Inc (ELTP)

[ARbigguy1]

Billions $$ in market potential coming to ELITE PHARMA IN less than a year!!!!!!!! 

JUST 1% for the 2 approved puts ELITE at $5.3 MILLION, 5% = $26.5 MILLION. Revenue IS COMING!!!!!!!! 

Approved - generic version of Percocet - QuintilesIMS Health data for the twelve months ending May 31, 2018, the retail sales for the brand and generic products were approximately $500 million. 

APPROVED! - generic version of a synthetic narcotic analgesic - Based on QuintilesIMS Health data, the annual retail sales for the brand and generic products were approximately $30 million. 

AND MORE APPROVALS COMING!!!!!!!!

SOON! - generic version of Norco - $700 million according to IMS Health data. 

SOON! - generic version of OxyContin - IMS reported approximately $2.3 billion in revenue for OxyContin® and its equivalents in 2016. 

December 2018 (10 months) to Early 2019 - Elite/SunGen - generic version of an immediate release central nervous system (“CNS”) stimulant - IMS Health data, the branded product and its equivalents had total U.S. sales of more than $400 million for the twelve months ended September 30, 2017. 

March 2019 (10 months) - Elite/SunGen - generic version of an extended release CNS stimulant - total U.S. sales of approximately $1.6 billion for the twelve months ended September 30, 2017. 

$500 million + $700 Million + $30 million + $2.3 BILLION + $400 million + $1.6 BILLION = $5.44 BILLION market opening up to Elite (ELTP).